These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 6222896

  • 1. In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
    Bauernfeind A, Petermüller C.
    Eur J Clin Microbiol; 1983 Apr; 2(2):111-5. PubMed ID: 6222896
    [Abstract] [Full Text] [Related]

  • 2. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [Abstract] [Full Text] [Related]

  • 3. Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy.
    Hoogkamp-Korstanje JA.
    Eur J Clin Microbiol; 1984 Aug; 3(4):333-8. PubMed ID: 6237901
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.
    Wise R, Andrews JM, Edwards LJ.
    Antimicrob Agents Chemother; 1983 Apr; 23(4):559-64. PubMed ID: 6222695
    [Abstract] [Full Text] [Related]

  • 5. The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.
    King A, Shannon K, Phillips I.
    J Antimicrob Chemother; 1984 Apr; 13(4):325-31. PubMed ID: 6233249
    [Abstract] [Full Text] [Related]

  • 6. Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
    Muytjens HL, van der Ros-van de Repe J, van Veldhuizen G.
    Antimicrob Agents Chemother; 1983 Aug; 24(2):302-4. PubMed ID: 6227281
    [Abstract] [Full Text] [Related]

  • 7. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
    Piccolomini R, Allocati N, Catamo G.
    Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
    [Abstract] [Full Text] [Related]

  • 8. The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients.
    Guimaraes MA, Noone P.
    J Antimicrob Chemother; 1986 Jan; 17(1):63-7. PubMed ID: 2936708
    [Abstract] [Full Text] [Related]

  • 9. In-vitro studies with ciprofloxacin, a new 4-quinolone compound.
    Reeves DS, Bywater MJ, Holt HA, White LO.
    J Antimicrob Chemother; 1984 Apr; 13(4):333-46. PubMed ID: 6233250
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of ciprofloxacin (Bay o 9867).
    Fass RJ.
    Antimicrob Agents Chemother; 1983 Oct; 24(4):568-74. PubMed ID: 6228192
    [Abstract] [Full Text] [Related]

  • 11. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM, Baltch AL, Smith RP.
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [Abstract] [Full Text] [Related]

  • 12. Antibacterial activity of norfloxacin.
    Norrby SR, Jonsson M.
    Antimicrob Agents Chemother; 1983 Jan; 23(1):15-8. PubMed ID: 6219617
    [Abstract] [Full Text] [Related]

  • 13. A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
    Shrire L, Saunders J, Traynor R, Koornhof HJ.
    Eur J Clin Microbiol; 1984 Aug; 3(4):328-32. PubMed ID: 6237900
    [Abstract] [Full Text] [Related]

  • 14. Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates.
    Forsgren A.
    Scand J Infect Dis; 1985 Aug; 17(1):91-4. PubMed ID: 3158070
    [Abstract] [Full Text] [Related]

  • 15. Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
    Traub WH.
    Chemotherapy; 1985 Aug; 31(1):34-9. PubMed ID: 3156026
    [Abstract] [Full Text] [Related]

  • 16. Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.
    Barry AL, Jones RN, Thornsberry C, Ayers LW, Gerlach EH, Sommers HM.
    Antimicrob Agents Chemother; 1984 May; 25(5):633-7. PubMed ID: 6233935
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates.
    Esposito S, Galante D, Pennucci C, Barba D, Limauro D, Scioli C.
    Chemioterapia; 1984 Jun; 3(3):196-9. PubMed ID: 6241506
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [In vitro antibacterial activity of ciprofloxacin against uropathogenic organisms].
    Allocati N, Catamo G, Cellini L.
    Boll Soc Ital Biol Sper; 1984 Oct 30; 60(10):1927-33. PubMed ID: 6440583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.